RAPT Therapeutics, Inc. (RAPT) Other Accumulated Expenses (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Other Accumulated Expenses for 5 consecutive years, with $168000.0 as the latest value for Q3 2024.
- Quarterly Other Accumulated Expenses rose 7.69% to $168000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $168000.0 through Sep 2024, up 7.69% year-over-year, with the annual reading at $178000.0 for FY2023, 25.21% down from the prior year.
- Other Accumulated Expenses hit $168000.0 in Q3 2024 for RAPT Therapeutics, up from $30000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $389000.0 in Q3 2020 to a low of $30000.0 in Q2 2024.
- Historically, Other Accumulated Expenses has averaged $151105.3 across 5 years, with a median of $164000.0 in 2020.
- Biggest five-year swings in Other Accumulated Expenses: tumbled 89.97% in 2021 and later soared 374.36% in 2023.
- Year by year, Other Accumulated Expenses stood at $263000.0 in 2020, then dropped by 3.42% to $254000.0 in 2021, then decreased by 6.3% to $238000.0 in 2022, then fell by 25.21% to $178000.0 in 2023, then fell by 5.62% to $168000.0 in 2024.
- Business Quant data shows Other Accumulated Expenses for RAPT at $168000.0 in Q3 2024, $30000.0 in Q2 2024, and $82000.0 in Q1 2024.